companydata.dkNovo Nordisk Research Center Gladsaxe ApS: Financial statements 2025
CVR: 39119374
Novo Nordisk Research Center Gladsaxe ApS (CVR 39119374) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -1,000 and a net result of DKK 48,000 compared with DKK 6,174,000 the year before. Equity amounted to DKK 807,000. The solvency ratio was 96.9%.
- Gross Profit
- -1,000 kr.
- Profit/Loss
- 48,000 kr.
- Equity
- 807,000 kr.
- Total Assets
- 833,000 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -1 t. | 48 t. | 807 t. | 0 |
| 2024 | - | -38 t. | 6.2 mio. | 6.8 mio. | 0 |
| 2023 | - | - | 395.5 mio. | 405.6 mio. | 2 |
| 2022 | - | 379 t. | -8.8 mio. | -5.9 mio. | 4 |
| 2021 | - | 0 | -6.2 mio. | 2.9 mio. | 3 |
Find more companies like Novo Nordisk Research Center Gladsaxe ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
As of December 3, 2025, Rikke Ryttergaard Andersen is registered as adm. dir. of Novo Nordisk Research Center Gladsaxe ApS.
As of December 3, 2025, Trine Haastrup has stepped down as director of Novo Nordisk Research Center Gladsaxe ApS.
Novo Nordisk Research Center Gladsaxe ApS has published its annual report for 2024. Gross profit came to DKK -38,000, and the net result was DKK 6,174,000.
About Novo Nordisk Research Center Gladsaxe ApS
Novo Nordisk Research Center Gladsaxe ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Embark Biotech ApS and Embark Biotech IvS. The management consists of Rikke Ryttergaard Andersen. The company is owned by NOVO NORDISK A/S. The company has 7 employees. In 2025, the company reported a gross profit of DKK -1,000 and a net result of DKK 48,000 compared with DKK 6,174,000 the year before. Equity amounted to DKK 807,000.